Research Article | | Peer-Reviewed

Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023)

Received: 24 December 2024     Accepted: 27 January 2025     Published: 26 February 2025
Views:       Downloads:
Abstract

Background: This study assesses the retention rate of patients living with HIV in the antiretroviral treatment (ART) program at Donka the National Hospital, Guinea, and identifies predictors of non-retention. Methods: Conducted as a retrospective cohort study from May 2018 to March 2023, it involved 4,169 HIV-positive patients aged 10 and older, who had been on antiretroviral treatment program for at least six months. Retention rates were estimated using Kaplan-Meier techniques, and multivariate Cox regression identified factors associated with non-retention. Results: Results showed a cumulative retention rate of 68.88%, declining over time: 91.3% at six months, 74.1% at 24 months, and 53.1% at 60 months. The study identified significant predictors of non-retention, including low CD4 counts (<100 cells/mm³: adjusted HR 2.158; 100-200 cells/mm³: adjusted HR 1.729), advanced HIV stages (III/IV) at treatment initiation (adjusted HR 1.335), and the use of "AZT + 3TC + NVP" regimen (adjusted HR 1.443). Most participants were women (66.2%) with a median age of 37 years, and a majority were unemployed (57.8%). Conclusion: The findings highlight a retention rate below the national target of 90%, with late treatment initiation and low CD4 counts as major barriers. The study calls for further qualitative and quantitative research to understand patient loss to follow-up and improve ART program retention and HIV care in Guinea.

Published in Science Journal of Public Health (Volume 13, Issue 1)
DOI 10.11648/j.sjph.20251301.18
Page(s) 70-81
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Antiretroviral Treatment, HIV/AIDS, Retention, Factors Associated, Conakry

References
[1] Montagnier L. Historical essay. A history of HIV discovery. Science. 2002 Nov 29; 298(5599): 1727-8.
[2] Seifu, W., Ali, W. & Meresa, B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis 18, 280 (2018).
[3] USAIDS. Global HIV & AIDS statistics — Fact sheet. 2023.
[4] Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W. Rapid scale-up of antiretroviral treatment in Ethiopia: Suc-cesses and system-wide effects. PLoS Med. 2009 Apr; 6(4).
[5] Chan AK, Mateyu G, Jahn A, Schouten E, Arora P, Mlotha W, et al. Outcome assessment of decentralization of an-tiretroviral therapy provision in a rural district of Malawi us-ing an integrated primary care model. Tropical Medicine and International Health. 2010 Jun; 15(SUPPL. 1): 90-7.
[6] Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Af-rica, 2007-2009: systematic review. Trop Med Int Health. 2010 Jun; 15 Suppl 1(s1): 1-15.
[7] Vuylsteke B, Semdé G, Auld AF, Sabatier J, Kouakou J, Ettiègne-Traoré V, et al. Retention and risk factors for loss to follow-up of female and male sex workers on antiretro-viral treatment in ivory coast: A retrospective cohort analy-sis. J Acquir Immune Defic Syndr (1988). 2015 Mar 1; 68: S99-106.
[8] Ajeh RA, Gregory HE, Thomas EO, Noela NA, Dzudie A, Jules AN, et al. Determinants of retention in hiv antiretrovi-ral treatment (Art) in the cameroon international epidemiol-ogy database to evaluate aids (iedea) study clinics: The con-text of the hiv treat all strategy in cameroon. Pan African Medical Journal. 2021 Sep 1; 40.
[9] Asiimwe SB, Kanyesigye M, Bwana B, Okello S, Muyindike W. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa. BMC In-fect Dis. 2016 Feb 1; 16(1).
[10] Olivier Kadio KJJ, Amadou C, Thierno SD, Guilavogui F, Adrien FT, Damey P, et al. Retention in care among people living with HIV in the national antiretroviral therapy pro-gramme in Guinea: A retrospective cohort analysis. PLOS Global Public Health. 2023 May 1; 3(5).
[11] Leno NN, Guilavogui F, Camara A, Kadio KJJO, Guilavo-gui T, Diallo TS, et al. Retention and Predictors of Attrition Among People Living With HIV on Antiretroviral Therapy in Guinea: A 13-Year Historical Cohort Study in Nine Large-Volume Sites. Int J Public Health. 2023; 68.
[12] ONUSIDA. Comprendre les mesures des progrès réalisés pour atteindre les objectifs 95-95-95 en matière de dépis-tage, de traitement et de suppression virale du VIH [Inter-net]. 2023 [cited 2024 Nov 11]. Available from:
[13] Comité National de Lutte contre le Sida Guinée. Cadre stratégique national de lutte contre le sida 2021 - 2025. CNLS. 2021.
[14] Ministère de la Santé Guinée. Plan National de Développe-ment Sanitaire (PNDS) de la Guinée 2015 - 2024. 2015.
[15] Programme National de Lutte contre le Sida et les Hépatites. Politiques, Normes et Protocoles de prise en charge de l’infection par le VIH chez l’adulte et l’enfant en Guinée. 2019.
[16] Vuylsteke B, Semdé G, Auld AF, Sabatier J, Kouakou J, Ettiègne-Traoré V, et al. Retention and risk factors for loss to follow-up of female and male sex workers on antiretro-viral treatment in ivory coast: A retrospective cohort analy-sis. J Acquir Immune Defic Syndr (1988). 2015 Mar 1; 68: S99-106.
[17] Brinkhof MWG, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income coun-tries. Bull World Health Organ. 2008 Jul; 86(7): 559-67.
[18] Molfino L, Kumar AMV, Isaakidis P, Van den Bergh R, Khogali M, Hinderaker SG, et al. High attrition among HIV-infected patients with advanced disease treated in an inter-mediary referral center in Maputo, Mozambique. Glob Health Action. 2014; 7(1).
[19] Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: A meta-ethnography. Tropical Medicine and International Health. 2010 Jun; 15(SUPPL. 1): 16-33.
[20] Hosseinipour MC, Neuhann FH, Kanyama CC, Namarika DC, Weigel R, Miller W, et al. Lessons learned from a pay-ing antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience. J Int Assoc Physicians AIDS Care. 2006 Sep; 5(3): 103-8.
[21] Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Vol. 15, Tropical Medicine and Internation-al Health. 2010. p. 70-5.
[22] Teshale AB, Tsegaye AT, Wolde HF (2020) Incidence et facteurs prédictifs de perte de suivi chez les patients adultes atteints du VIH sous traitement antirétroviral à l’hôpital spé-cialisé complet de l’université de Gondar: une modélisation par régression des risques concurrents. PLoS ONE 15(1): e0227473.
[23] Tadesse K, Haile F (2014) Predictors of Loss to Follow Up of Patients Enrolled on Antiretroviral Therapy: A Retrospec-tive Cohort Study. J AIDS Clin Res 5: 393.
Cite This Article
  • APA Style

    Leno, N. N., Sovogui, P. P., Ma-Nitu, S. M., Condé, I. S., Loua, O., et al. (2025). Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023). Science Journal of Public Health, 13(1), 70-81. https://doi.org/10.11648/j.sjph.20251301.18

    Copy | Download

    ACS Style

    Leno, N. N.; Sovogui, P. P.; Ma-Nitu, S. M.; Condé, I. S.; Loua, O., et al. Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023). Sci. J. Public Health 2025, 13(1), 70-81. doi: 10.11648/j.sjph.20251301.18

    Copy | Download

    AMA Style

    Leno NN, Sovogui PP, Ma-Nitu SM, Condé IS, Loua O, et al. Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023). Sci J Public Health. 2025;13(1):70-81. doi: 10.11648/j.sjph.20251301.18

    Copy | Download

  • @article{10.11648/j.sjph.20251301.18,
      author = {Niouma Nestor Leno and Pierre Pepe Sovogui and Serge Mayaka Ma-Nitu and Iya Saidou Condé and Oscar Loua and Albert Camara and Alioune Camara and Alexandre Delamou},
      title = {Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023)
    },
      journal = {Science Journal of Public Health},
      volume = {13},
      number = {1},
      pages = {70-81},
      doi = {10.11648/j.sjph.20251301.18},
      url = {https://doi.org/10.11648/j.sjph.20251301.18},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20251301.18},
      abstract = {Background: This study assesses the retention rate of patients living with HIV in the antiretroviral treatment (ART) program at Donka the National Hospital, Guinea, and identifies predictors of non-retention. Methods: Conducted as a retrospective cohort study from May 2018 to March 2023, it involved 4,169 HIV-positive patients aged 10 and older, who had been on antiretroviral treatment program for at least six months. Retention rates were estimated using Kaplan-Meier techniques, and multivariate Cox regression identified factors associated with non-retention. Results: Results showed a cumulative retention rate of 68.88%, declining over time: 91.3% at six months, 74.1% at 24 months, and 53.1% at 60 months. The study identified significant predictors of non-retention, including low CD4 counts (Conclusion: The findings highlight a retention rate below the national target of 90%, with late treatment initiation and low CD4 counts as major barriers. The study calls for further qualitative and quantitative research to understand patient loss to follow-up and improve ART program retention and HIV care in Guinea.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Associated Factors with Non-retention of People Living with HIV in the Antiretroviral Treatment Program at the Donka National Hospital, Conakry: A Five-year Retrospective Cohort Study (2018 - 2023)
    
    AU  - Niouma Nestor Leno
    AU  - Pierre Pepe Sovogui
    AU  - Serge Mayaka Ma-Nitu
    AU  - Iya Saidou Condé
    AU  - Oscar Loua
    AU  - Albert Camara
    AU  - Alioune Camara
    AU  - Alexandre Delamou
    Y1  - 2025/02/26
    PY  - 2025
    N1  - https://doi.org/10.11648/j.sjph.20251301.18
    DO  - 10.11648/j.sjph.20251301.18
    T2  - Science Journal of Public Health
    JF  - Science Journal of Public Health
    JO  - Science Journal of Public Health
    SP  - 70
    EP  - 81
    PB  - Science Publishing Group
    SN  - 2328-7950
    UR  - https://doi.org/10.11648/j.sjph.20251301.18
    AB  - Background: This study assesses the retention rate of patients living with HIV in the antiretroviral treatment (ART) program at Donka the National Hospital, Guinea, and identifies predictors of non-retention. Methods: Conducted as a retrospective cohort study from May 2018 to March 2023, it involved 4,169 HIV-positive patients aged 10 and older, who had been on antiretroviral treatment program for at least six months. Retention rates were estimated using Kaplan-Meier techniques, and multivariate Cox regression identified factors associated with non-retention. Results: Results showed a cumulative retention rate of 68.88%, declining over time: 91.3% at six months, 74.1% at 24 months, and 53.1% at 60 months. The study identified significant predictors of non-retention, including low CD4 counts (Conclusion: The findings highlight a retention rate below the national target of 90%, with late treatment initiation and low CD4 counts as major barriers. The study calls for further qualitative and quantitative research to understand patient loss to follow-up and improve ART program retention and HIV care in Guinea.
    
    VL  - 13
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Public Health, Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; African Center of Excellence for Infection Prevention and Control, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • African Center of Excellence for Infection Prevention and Control, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • National School of Public Health of Kinshasa, Kinshasa, Democratic Republic of Congo

  • Ministry of Health and Public Hygiene, Conakry, Guinea

  • Ministry of Health and Public Hygiene, Conakry, Guinea

  • Ministry of Health and Public Hygiene, Conakry, Guinea

  • Department of Public Health, Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; African Center of Excellence for Infection Prevention and Control, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • Department of Public Health, Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; African Center of Excellence for Infection Prevention and Control, Gamal Abdel Nasser University of Conakry, Conakry, Guinea

  • Sections